Tagrix 80 Mg, containing the active ingredient Osimertinib, is a targeted therapy drug used in the treatment of non-small cell lung cancer (NSCLC). It specifically targets and inhibits the activity of the epidermal growth factor receptor (EGFR) mutations, which are often responsible for the growth a...